Share this post on:

Product Name :
Afabicin

Search keywords :
AFN-1252

drugId :
null

Target Vo:
Enoyl-acyl-carrier protein reductase

Target Vo Short Name :
ENR

Moa_Name:
Enoyl-acyl-carrier protein reductase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :
Debiopharm International Sa

Active Indication_Name:
Joint Diseases

In Active Indication_Name:
Bone Diseases, Infectious

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-Mouse TCR gamma/delta Antibody (UC7-13D5) site
Axatilimab Protocol
GAPDH Antibody (HRP) (YA874): GAPDH Antibody (HRP) (YA874) is a mouse-derived, anti-GAPDH (HRP) (YA874) monoclonal antibody. GAPDH Antibody (HRP) (YA874) can be used for: WB, ELISA expriments in human, mouse, rat background with HRP labeling.

Share this post on:

Author: Interleukin Related